1 |
Najjar VA, Nishiska K. Tuftsin: A physiological phagocycosis stimulating peptide.Nature,1970,288(2):672-676.
|
2 |
汪谦.脾脏因子Tuftsin 研究进展.中华实验外科杂志,1995,122(1):62-64.
|
3 |
Trevisani F, Castelli EG, Foschi F, et al. Impaired tuftsin activity in cirrhosis:relationship with splenic function and clinical outcome.Gut,2002,50(5):707-712.
|
4 |
Oscier D,Owen R,Johnson S.Splenic marginal zone lymphoma.Blood Rew,2005,19(1):39-51.
|
5 |
易坚.脾脏与肿瘤.免疫实用癌症杂志,1999,14(3):239-240.
|
6 |
赵明耀,杨洪艳,黄幼田,等.树突状细胞对去脾小鼠荷S180 瘤的治疗效果.郑州大学学报(医学版),2002,37(2):150-152.
|
7 |
葛依工,高瀚,孔宪涛,等.脾脏切除对大鼠移植性肝癌生长和外周血T 淋巴细胞亚群变化的影响. 中华外科杂志, 1989, 27(5):305-307.
|
8 |
刘骞,王成峰,赵平,等.保脾术式对胰体尾癌患者细胞免疫功能及预后的影响.中国微创外科杂志2007,7(10):989-991.
|
9 |
Okinaga K,Iinuma H,Kitamura Y,et al.Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer.J Exp Clin Cancer Res,2006,25(3):339-349.
|
10 |
Zhang CH, Zhan WH, He YL, et al. Spleen preservation in radical surgery for gastric cardia cancer.Ann Surg Oncol,2007,14(4):1312-1319.
|
11 |
Erturk S,Ersan Y,Cicek Y,et al.Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma. Surg Today,2003,33(4):254-258.
|
12 |
Fatouros M, Roudos DH, Lorenz M, et al. Impact of spleen preservation in patients with gastric cancer. Anticancer Res, 2005, 25(4):30 23-3030.
|
13 |
戴兆云,章宏海,黄伟达.重组小鼠热休克蛋白70 对小鼠脾脏中NK 细胞的影响.中国现代医学杂志,18(5):122-124.
|